5 NMC Marketing Violations That Get Doctors Suspended India 2026 | ICG

Author: Rohit Gupta · Co-Founder, ICG · July 2026

NMC Section 6 enforcement is complaint-driven. Most violations result in a formal warning — the first step in a progressive penalty system. But five violation types consistently appear in cases that escalate beyond warnings to formal censure or registration suspension. ICG's compliance programme is designed specifically to eliminate all five.

Violation 1: Before-and-after imagery of identifiable patients

Why it generates the most complaints: Cosmetic procedure patients who feel their actual outcome fell short of what the before-and-after suggested are the most likely to file a formal NMC complaint. The emotional weight of the perception of being misled about a physical outcome creates strong complaint motivation.

Why it escalates to suspension: Repeated violations after formal warning, or a first violation involving significant patient harm (psychological distress from the outcome gap), can escalate beyond the standard warning trajectory.

The ICG protocol: No before-and-after of identifiable patients under any circumstances, regardless of consent. Patient journey testimonials (journey format, DPDP consent, no outcome comparison) replace before-and-after in all client content.

Violation 2: IVF success rate advertising

Why it generates complaints: The ART Act 2021 Section 26 prohibition is specific and absolute. IVF patients who experience unsuccessful cycles and then encounter the clinic's success rate advertising feel directly misled. Complaint rates have increased as ART Act 2021 awareness has grown among patient advocacy groups.

Why it escalates: The ART Act is a specific statutory violation, not just an NMC ethics provision. Violations may involve both NMC disciplinary action and ART Registry consequences.

The ICG protocol: Zero success rate claims in any IVF marketing content. Published ICMR population-level statistics with attribution and individual-variability qualifiers are used instead.

Violation 3: Paid patient testimonials

Why it generates complaints: Patients who discover that a testimonial they relied on in their healthcare decision was paid — or incentivised in any way — have strong grounds for both an NMC complaint and a Consumer Protection Act complaint. Incentivised reviews on Google and Practo also violate those platforms' policies, leading to review removal and potential account action.

Why it escalates: Financial inducement to solicit patients is a Section 6 violation with commercial gain implications that can be viewed more seriously than non-financial violations.

The ICG protocol: Zero incentivised testimonials or reviews under any circumstances. The Hawk post-consultation review request asks for an honest review — no rating specified, no incentive offered.

Violation 4: Commercial endorsement of drugs and supplements without Section 6 compliance

Why it generates complaints: The 2026 NMC revision's influencer provision creates a new category of complaining parties: patients who followed a doctor's supplement or wellness product endorsement on Instagram, purchased the product, and experienced adverse effects or unsatisfactory results. The doctor's paid endorsement of the product is now clearly within Section 6's scope — creating a path from patient complaint to NMC review.

Why it escalates: Financial gain from the endorsement arrangement is aggravating in NMC disciplinary proceedings.

The ICG protocol: For doctor clients with endorsement arrangements: review each arrangement against the 2026 NMC influencer provision. Arrange for product claims to be reviewed for FSSAI/AYUSH compliance. Ensure all content meets NMC Section 6 standards before publishing.

Violation 5: Competitor disparagement

Why it generates complaints: In competitive urban markets for cosmetic specialties, competitor-filed NMC complaints for Section 3 disparagement (indirect, through implication that competitors are inferior) combined with Section 6 violations are increasingly used as a competitive tool. A post that implies "other clinics in [city] don't achieve results like ours" is both a superlative claim (Section 6.3) and potential professional disparagement (Section 3).

Why it escalates: Combined Section 3 + Section 6 violations with evidence of deliberate competitive intent are viewed seriously.

The ICG protocol: All client content avoids any reference, direct or implied, to competitor quality. Competitive differentiation is achieved through factual credential and data claims ("57 IVF clients, ₹1,180 median CPQL") not through comparative diminishment.

FAQ

Q1: If a complaint is filed against me, what is the process? The complainant submits a written complaint to the NMC or relevant state medical council. The council issues a show-cause notice to the doctor. The doctor submits a written response. An inquiry committee may be appointed for serious cases. The penalty range: formal warning, public censure, registration suspension (temporary or permanent for the most serious violations). Timeline: 6-18 months for the full process in most cases.

Q2: Does ICG's compliance programme guarantee I won't receive a complaint? No programme can guarantee zero complaints — anyone can file a complaint regardless of merit. ICG's compliance programme eliminates the most commonly targeted violation types from client content, significantly reducing the foundation for a successful complaint. ICG's portfolio track record (zero formal complaints across 150+ clients since 2018) reflects the effectiveness of systematic compliance rather than luck.

Q3: Can a competitor file an NMC complaint against me? Yes. NMC complaints can be filed by any person — patients, competitors, patient advocacy groups, or members of the public. Competitor-filed complaints based on specific NMC violations (before-and-after imagery, superlative claims, success rate advertising) are a documented pattern in competitive urban healthcare markets. ICG's compliance programme specifically eliminates the violation types most commonly targeted in competitor complaints.

Compliance note: NMC Section 6, Section 3, ART Act 2021 Section 26, DPDP Act 2023.